Genetically modified bacillus subtilis strain and use as a live delivery and production system
US-2024390433-A1 · Nov 28, 2024 · US
US2018265875A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2018265875-A1 |
| Application number | US-201515307455-A |
| Country | US |
| Kind code | A1 |
| Filing date | Mar 4, 2015 |
| Priority date | Mar 4, 2015 |
| Publication date | Sep 20, 2018 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed herein is Candida parapsilosis CGMCC 9630, the carbonyl reductase expressed by said strain and the encoding gene and amino acid sequence thereof, the recombinant expression vector and recombinant expression transformant containing said gene sequence, and use of whole cells of Candida parapsilosis, carbonyl reductase or corresponding recombinant transformant thereof as catalyst in catalyzing asymmetric reduction of prochiral carbonyl compounds, particularly reduction of 6-carbonyl-8-halogenocaprylate to prepare the synthetic precursor of (R)-α-lipoic acid, (R)-6-hydroxy-8-halogenocaprylate. In comparison to other methods of asymmetric reduction for preparing (R)-6-hydroxy-8-halogenocaprylate, the disclosure has advantages of high substrate concentration, mild reaction conditions, environmental friendship, high yield, and high optical purity of the product, and thus has good prospect in industrial production of (R)-α-α-lipoic acid.
Opening claim text (preview).
1 . A Candida parapsilosis with the deposit number CGMCC 9630, wherein the Candida parapsilosis is able to express a carbonyl reductase. 2 . A carbonyl reductase, wherein the amino acid sequence of the carbonyl reductase is as set forth in SEQ ID Nos. 2, 4 or 6. 3 . A carbonyl reductase encoding gene, wherein the gene is: (1) a nucleotide sequence as set forth in SEQ ID Nos. 1, 3 or 5; (2) an encoding gene of a protein with an amino acid sequence as set forth in SEQ ID Nos. 2, 4 or 6. 4 . A recombinant expression vector, wherein the vector comprises the gene according to claim 3 , and optionally an encoding gene of a glucose dehydrogenase, wherein the glucose dehydrogenase is as set forth in SEQ ID No. 14. 5 . A recombinant expression transformant, wherein the transformant comprises the recombinant expression vector according to claim 4 . 6 . A method of preparing a carbonyl reductase, wherein the method comprises a step of culturing the Candida parapsilosis according to claim 1 . 7 . The method of claim 6 , further comprising catalyzing an asymmetric reduction reaction of prochiral carbonyl compounds using the carbonyl reductase as a catalyst in the reduction reaction. 8 . The method according to claim 7 , wherein the concentration of the prochiral carbonyl compounds is 1 to 1500 mmol/L, and the amount of the carbonyl reductase is optionally 8.0˜800 U/mmol prochiral carbonyl compounds. 9 . The method according to claim 7 , wherein in the asymmetric reduction reaction, (1) NADPH or (2) glucose dehydrogenase, glucose and NADP + are further added, and the amount of addition for coenzyme NADPH is 0 to 10 mmol/L, if added, the amount of addition for glucose dehydrogenase is 0 to 340 U/mmol prochiral carbonyl compounds, if added, the amount of addition for glucose is 0 to 0.3 g/mmol prochiral carbonyl compounds, if added, and the amount of addition for coenzyme NADP + is 0 to 1.0 mmol/L, if added. 10 . The method according to claim 7 , wherein the prochiral carbonyl compounds are selected from the followings: wherein R 1 is selected from —CH 2 (CH 3 ) 2 , -2-Cl—C 6 H 4 and —(CH 2 ) 2 C 6 H 5 ; R 2 is —CH 3 or —CH 2 CH 3 ; R 3 is —CH 2 Cl, —CH 2 CH 3 or —(CH 2 ) 2 CH 3 ; R 4 is —CH 3 or —CH 2 CH 3 . 11 . The method according to claim 10 , wherein the prochiral carbonyl compound is ethyl 6-carbonyl-8-chlorocaprylate.
Yeasts; Culture media therefor · CPC title
Hydroxy-carboxylic acids · CPC title
Carbonyl reductase (NADPH) (1.1.1.184) · CPC title
Chemistry & Metallurgy · mapped topic
for yeasts · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.